What’s next for GLP-1 weight loss drugs? - Takeaways - MDSpire

What’s next for GLP-1 weight loss drugs?

  • By

  • Alex Hogan

  • June 18, 2026

  • 0 min

Share

  • 1

    GLP-1 weight loss drugs like Wegovy and Zepbound have gained significant popularity in recent years.

  • 2

    Pharmaceutical companies such as Pfizer and Amgen are developing competing GLP-1 medications.

  • 3

    Novo Nordisk and Eli Lilly are working on strategies to maintain their dominance in the weight loss market.

  • 4

    The STATus Report discusses the competitive landscape of GLP-1 medications.

  • 5

    Insights from the STAT colleagues on the GLP-1 news cycle are featured in the report.

Original Source(s)

What’s next for GLP-1 weight loss drugs?

  • by Alex Hogan

  • June 18, 2026

Related Content

Nationwide prospective cohort study in China: the impact of cumulative modified cardiometabolic index on cardiovascular disease incidence

Sex disparities in body composition trends among elementary school students based on grade

Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial